跳至主要内容
临床试验/NCT04829487
NCT04829487Unknown不适用

The Role of Vitamin D Supplementation on Pain in Women With Primary Dysmenorrhea and Hypovitaminosis D: A Randomized, Double-blind, Placebo-Controlled Study

Mahidol University0 个研究点目标入组 36 人开始时间: 2021年5月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
36
主要终点
Visual analog pain scale

研究概览

简要总结

The purpose of this study is to evaluate the effect of vitamin D supplementation on the pain score of primary dysmenorrhea. Our hypothesis is that by normalizing vitamin D level could help improve pain score of women who have primary dysmenorrhea.

详细描述

This study is aimed to be conducted in randomised controlled trial, comparing between intervention group and placebo group. We include women with primary dysmenorrhea who also have low vitamin D level in this trial. Our primary outcome is to compare visual analog pain scale between intervention and placebo group after treatment. After randomised and allocated, these women will be given vitamin D 50,000 IU or placebo capsules orally weekly for 8 consecutive weeks. We monitor pain score daily from the cycle before the drugs started until complete 8-week course of the regimen mentioned. Also vitamin D levels will be monitored twice, one before treatment and the other after treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 30 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Primary dysmenorrhea
  • Hypovitaminosis D

排除标准

  • Using calcium, magnesium or phosphorus in the past 3 months
  • Using hormonal contraception or IUD in the past 6 months
  • No smoking or alcohol drinking
  • Chronic underlying diseases
  • Allergic to components in study drugs

研究组 & 干预措施

Vitamin D

Experimental

Vitamin D 50,000 IU orally weekly for 8 weeks

干预措施: Ergocalciferol Capsules (Drug)

Placebo

Placebo Comparator

Placebo capsules orally weekly for 8 weeks

干预措施: Placebo (Drug)

结局指标

主要结局

Visual analog pain scale

时间窗: 8 weeks

Pain score between intervention and placebo group after treatment

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Preeyaporn Jirakittidul

Doctor

Mahidol University

相似试验